214 related articles for article (PubMed ID: 16809213)
1. An open label pilot investigation of the efficacy of Botulinum toxin type A [Dysport] injection in the rehabilitation of chronic anterior knee pain.
Singer BJ; Silbert PL; Dunne JW; Song S; Singer KP
Disabil Rehabil; 2006 Jun; 28(11):707-13. PubMed ID: 16809213
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory anterior knee pain using botulinum toxin type A (Dysport) injection to the distal vastus lateralis muscle: a randomised placebo controlled crossover trial.
Singer BJ; Silbert PL; Song S; Dunne JW; Singer KP
Br J Sports Med; 2011 Jun; 45(8):640-5. PubMed ID: 20418523
[TBL] [Abstract][Full Text] [Related]
4. Prolonged vastus lateralis denervation after botulinum toxin type A injection.
Dunne JW; Singer BJ; Silbert PL; Singer KP
Mov Disord; 2010 Feb; 25(3):397-401. PubMed ID: 20108381
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.
Truong D; Brodsky M; Lew M; Brashear A; Jankovic J; Molho E; Orlova O; Timerbaeva S;
Parkinsonism Relat Disord; 2010 Jun; 16(5):316-23. PubMed ID: 20359934
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin injection to facilitate rehabilitation of muscle imbalance syndromes in sports medicine.
Cullen DM; Boyle JJ; Silbert PL; Singer BJ; Singer KP
Disabil Rehabil; 2007 Dec; 29(23):1832-9. PubMed ID: 18033608
[TBL] [Abstract][Full Text] [Related]
8. Disability in patients with chronic patellofemoral pain syndrome: a randomised controlled trial of VMO selective training versus general quadriceps strengthening.
Syme G; Rowe P; Martin D; Daly G
Man Ther; 2009 Jun; 14(3):252-63. PubMed ID: 18436468
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
Carroll A; Barnes M; Comiskey C
Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
Lew HL; Lee EH; Castaneda A; Klima R; Date E
Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
Truong D; Duane DD; Jankovic J; Singer C; Seeberger LC; Comella CL; Lew MF; Rodnitzky RL; Danisi FO; Sutton JP; Charles PD; Hauser RA; Sheean GL
Mov Disord; 2005 Jul; 20(7):783-91. PubMed ID: 15736159
[TBL] [Abstract][Full Text] [Related]
13. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.
Suputtitada A; Suwanwela NC
Disabil Rehabil; 2005 Feb; 27(4):176-84. PubMed ID: 15824048
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A injection in alleviating postoperative pain and improving quality of life in lower extremity limb lengthening and deformity correction: a pilot study.
Hamdy RC; Montpetit K; Raney EM; Aiona MD; Fillman RR; MacKenzie W; McCarthy J; Chafetz RS; Thomas SS; Tamayo CM; Littleton AG; Ruck-Gibis J; Takahashi SN; Rinaldi M; Finley GA; Platt RW; Dahan-Oliel N
J Pediatr Orthop; 2009; 29(5):427-34. PubMed ID: 19568011
[TBL] [Abstract][Full Text] [Related]
15. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
Grosse J; Kramer G; Jakse G
BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
[TBL] [Abstract][Full Text] [Related]
16. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis.
Giovannelli M; Borriello G; Castri P; Prosperini L; Pozzilli C
Clin Rehabil; 2007 Apr; 21(4):331-7. PubMed ID: 17613573
[TBL] [Abstract][Full Text] [Related]
17. Pain induced by injection of hypertonic saline into the infrapatellar fat pad and effect on coordination of the quadriceps muscles.
Hodges PW; Mellor R; Crossley K; Bennell K
Arthritis Rheum; 2009 Jan; 61(1):70-7. PubMed ID: 19116977
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A for the treatment of chronic neck pain after neck dissection.
Vasan CW; Liu WC; Klussmann JP; Guntinas-Lichius O
Head Neck; 2004 Jan; 26(1):39-45. PubMed ID: 14724905
[TBL] [Abstract][Full Text] [Related]
19. The effect of additional strengthening of hip abductor and lateral rotator muscles in patellofemoral pain syndrome: a randomized controlled pilot study.
Nakagawa TH; Muniz TB; Baldon Rde M; Dias Maciel C; de Menezes Reiff RB; Serrão FV
Clin Rehabil; 2008 Dec; 22(12):1051-60. PubMed ID: 19052244
[TBL] [Abstract][Full Text] [Related]
20. Effects of vastus medialis oblique retraining versus general quadriceps strengthening on vasti onset.
Bennell K; Duncan M; Cowan S; McConnell J; Hodges P; Crossley K
Med Sci Sports Exerc; 2010 May; 42(5):856-64. PubMed ID: 19997004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
